Verughese Jacob1, Sajal K Chattopadhyay2, David P Hopkins2, Jeffrey A Reynolds2, Ka Zang Xiong2, Christopher D Jones3, Betsy J Rodriguez4, Krista K Proia4, Nicolaas P Pronk5, John M Clymer6, Ron Z Goetzel7. 1. Community Guide Branch, Division of Public Health Information Dissemination, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia. Electronic address: hir0@cdc.gov. 2. Community Guide Branch, Division of Public Health Information Dissemination, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia. 3. Division for Heart Disease and Stroke Prevention, Office of Noncommunicable Diseases, Injury, and Environmental Health, CDC, Atlanta, Georgia. 4. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia. 5. HealthPartners Institute, Minneapolis, Minnesota; Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 6. National Forum for Heart Disease and Stroke Prevention, Washington, District of Columbia. 7. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; IBM Watson Health, Bethesda, Maryland.
Abstract
CONTEXT: Cardiovascular disease in the U.S. accounted for healthcare cost and productivity losses of $330 billion in 2013-2014 and diabetes accounted for $327 billion in 2017. The impact is disproportionate on minority and low-SES populations. This paper examines the available evidence on cost, economic benefit, and cost effectiveness of interventions that engage community health workers to prevent cardiovascular disease, prevent type 2 diabetes, and manage type 2 diabetes. EVIDENCE ACQUISITION: Literature from the inception of databases through July 2016 was searched for studies with economic information, yielding nine studies in cardiovascular disease prevention, seven studies in type 2 diabetes prevention, and 13 studies in type 2 diabetes management. Analyses were done in 2017. Monetary values are reported in 2016 U.S. dollars. EVIDENCE SYNTHESIS: The median intervention cost per patient per year was $329 for cardiovascular disease prevention, $600 for type 2 diabetes prevention, and $571 for type 2 diabetes management. The median change in healthcare cost per patient per year was -$82 for cardiovascular disease prevention and -$72 for type 2 diabetes management. For type 2 diabetes prevention, one study saw no change and another reported -$1,242 for healthcare cost. One study reported a favorable 1.8 return on investment from engaging community health workers for cardiovascular disease prevention. Median cost per quality-adjusted life year gained was $17,670 for cardiovascular disease prevention, $17,138 (mean) for type 2 diabetes prevention, and $35,837 for type 2 diabetes management. CONCLUSIONS: Interventions engaging community health workers are cost effective for cardiovascular disease prevention and type 2 diabetes management, based on a conservative $50,000 benchmark for cost per quality-adjusted life year gained. Two cost per quality-adjusted life year estimates for type 2 diabetes prevention were far below the $50,000 benchmark. Published by Elsevier Inc.
CONTEXT: Cardiovascular disease in the U.S. accounted for healthcare cost and productivity losses of $330 billion in 2013-2014 and diabetes accounted for $327 billion in 2017. The impact is disproportionate on minority and low-SES populations. This paper examines the available evidence on cost, economic benefit, and cost effectiveness of interventions that engage community health workers to prevent cardiovascular disease, prevent type 2 diabetes, and manage type 2 diabetes. EVIDENCE ACQUISITION: Literature from the inception of databases through July 2016 was searched for studies with economic information, yielding nine studies in cardiovascular disease prevention, seven studies in type 2 diabetes prevention, and 13 studies in type 2 diabetes management. Analyses were done in 2017. Monetary values are reported in 2016 U.S. dollars. EVIDENCE SYNTHESIS: The median intervention cost per patient per year was $329 for cardiovascular disease prevention, $600 for type 2 diabetes prevention, and $571 for type 2 diabetes management. The median change in healthcare cost per patient per year was -$82 for cardiovascular disease prevention and -$72 for type 2 diabetes management. For type 2 diabetes prevention, one study saw no change and another reported -$1,242 for healthcare cost. One study reported a favorable 1.8 return on investment from engaging community health workers for cardiovascular disease prevention. Median cost per quality-adjusted life year gained was $17,670 for cardiovascular disease prevention, $17,138 (mean) for type 2 diabetes prevention, and $35,837 for type 2 diabetes management. CONCLUSIONS: Interventions engaging community health workers are cost effective for cardiovascular disease prevention and type 2 diabetes management, based on a conservative $50,000 benchmark for cost per quality-adjusted life year gained. Two cost per quality-adjusted life year estimates for type 2 diabetes prevention were far below the $50,000 benchmark. Published by Elsevier Inc.
Authors: Hans-Georg Eichler; Sheldon X Kong; William C Gerth; Panagiotis Mavros; Bengt Jönsson Journal: Value Health Date: 2004 Sep-Oct Impact factor: 5.725
Authors: Erin P Kane; Ashley W Collinsworth; Kathryn L Schmidt; Rachel M Brown; Christine A Snead; Sunni A Barnes; Neil S Fleming; James W Walton Journal: Fam Pract Date: 2016-07-14 Impact factor: 2.267
Authors: Ira S Ockene; Trinidad L Tellez; Milagros C Rosal; George W Reed; John Mordes; Philip A Merriam; Barbara C Olendzki; Garry Handelman; Robert Nicolosi; Yunsheng Ma Journal: Am J Public Health Date: 2011-12-15 Impact factor: 9.308
Authors: Sharon A Brown; Shelley A Blozis; Kamiar Kouzekanani; Alexandra A Garcia; Maria Winchell; Craig L Hanis Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: Garry R Barton; Mark Goodall; Peter Bower; Sue Woolf; Simon Capewell; Mark B Gabbay Journal: J Eval Clin Pract Date: 2011-04-24 Impact factor: 2.431
Authors: Robert L Ferrer; Carolina Gonzalez Schlenker; Inez Cruz; Polly Hitchcock Noël; Raymond F Palmer; Ramin Poursani; Carlos Roberto Jaén Journal: Ann Fam Med Date: 2022 Sep-Oct Impact factor: 5.707
Authors: Ashish V Gupta; Ajay G Phatak; Meha U Patel; Neha Das; Nirav P Vaghela; Harihara Prakash; Shyamsudar J Raithatha Journal: J Family Med Prim Care Date: 2020-04-30
Authors: Wen Ye; Shihchen Kuo; Edith C Kieffer; Gretchen Piatt; Brandy Sinco; Gloria Palmisano; Michael S Spencer; William H Herman Journal: Diabetes Care Date: 2021-05-06 Impact factor: 19.112
Authors: Gerardo Moreno; Carol M Mangione; Chi-Hong Tseng; Melanie Weir; Rosaneli Loza; Lisa Desai; Jonathan Grotts; Eve Gelb Journal: J Am Geriatr Soc Date: 2021-03-12 Impact factor: 7.538
Authors: Mayuree Rao; Maurits van Pelt; James LoGerfo; Lesley E Steinman; Hen Heang; Annette L Fitzpatrick Journal: PLoS One Date: 2020-06-25 Impact factor: 3.240